More
    Guided Solutions - Connecting Talent With Innovation/div>

    Orthocell completes FDA 510(k) regulatory study for Remplir™

    The regulatory study validated Remplir as a safe and effective biological medical device for use in the surgical repair of peripheral nerves and will...

    BrioHealth begins enrolment in LVAD study for its BrioVAD system

    BrioHealth Solutions enroled its first patients in the U.S. for the INNOVATE trial of its BrioVAD system. Burlington, Massachusetts–based BrioHealth has had its BrioVAD...

    EmStop completes trial of embolic protection system

    EmStop has completed the ‘Controlled Arterial Protection to Ultimately Remove Embolic Material’ (CAPTURE-1) early feasibility clinical study which assessed the EmStop embolic protection system. The...

    Supira begins early feasibility study for percutaneous ventricular assist device

    Supira Medical began patient enrolment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD). The Shifamed portfolio company plans to evaluate...

    EndoTheia completes first-in-human study of steerable kidney stone basket

    EndoTheia completed the first-in-human clinical trial for its FlexStone basket, a steerable kidney stone treatment. Nashville, Tennessee-based EndoTheia said its FlexStone basket represents the...

    Second Heart Assist’s Whisper device has successful case studies

    Second Heart Assist announced successful case studies in South America with its Whisper catheter-delivered heart assist device. Dr. Adrian Ebner, head of the cardiovascular...

    Tivic completes enrolment in nerve stim trial

    Tivic Health Systems completed enrollment in a study for its vagus nerve stimulation (VNS) device. The study, conducted by The Feinstein Institute of Bioelectronic Medicine,...

    Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer

    Aethlon Medical has enroled the first patient in its Australian clinical trial evaluating the safety, feasibility, and optimal dosing of the Hemopurifier device in...

    Vivasure sees success in absorbable large-bore vessel device trial

    Irish absorbable tech company, Vivasure Medical, has announced results from a US Investigational Device Exemption (IDE) PATCH pivotal trial finding that its fully absorbable...

    Latest articles